Structure-based design of novel melanin-concentrating hormone receptor-1 ligands based on saturated nitrogencontaining heterocycles.

[1]  Kaichao You,et al.  Identification and New Indication of Melanin-Concentrating Hormone Receptor 1 (MCHR1) Antagonist Derived from Machine Learning and Transcriptome-Based Drug Repositioning Approaches , 2022, International journal of molecular sciences.

[2]  J. Éles,et al.  hERG optimization of MCHR1 antagonist benzofuro-pyridine and pyrazino-indole derivatives. , 2022, ChemMedChem.

[3]  Shan Bian,et al.  Determination of the Interaction and Pharmacological Modulation of MCHR1 Signaling by the C-Terminus of MRAP2 Protein , 2021, Frontiers in Endocrinology.

[4]  S. Nauli,et al.  Regulation of Brain Primary Cilia Length by MCH Signaling: Evidence from Pharmacological, Genetic, Optogenetic, and Chemogenic Manipulations , 2021, Molecular Neurobiology.

[5]  E. Proschak,et al.  Spirocyclic Scaffolds in Medicinal Chemistry. , 2020, Journal of medicinal chemistry.

[6]  M. Avery,et al.  Identification of a new small molecule chemotype of Melanin Concentrating Hormone Receptor-1 antagonists using pharmacophore-based virtual screening. , 2019, Bioorganic & medicinal chemistry letters.

[7]  Marshall J. Allen,et al.  Synthetic Studies Toward Bazzanin K: Regioselective and Chemoselective Three-Component Suzuki Coupling. , 2019, The Journal of organic chemistry.

[8]  A. Gundlach,et al.  Melanin-concentrating hormone and orexin systems in rat nucleus incertus: Dual innervation, bidirectional effects on neuron activity, and differential influences on arousal and feeding , 2018, Neuropharmacology.

[9]  Douglas J. MacNeil,et al.  The Role of Melanin-Concentrating Hormone and Its Receptors in Energy Homeostasis , 2013, Front. Endocrinol..

[10]  S. Waldman,et al.  Central and Peripheral Molecular Targets for Antiobesity Pharmacotherapy , 2010, Clinical pharmacology and therapeutics.

[11]  B. Yates,et al.  Distribution of hypothalamic neurons with orexin (hypocretin) or melanin concentrating hormone (MCH) immunoreactivity and multisynaptic connections with diaphragm motoneurons , 2010, Brain Research.

[12]  C. Humblet,et al.  Escape from flatland: increasing saturation as an approach to improving clinical success. , 2009, Journal of medicinal chemistry.

[13]  Jill M. Wetter,et al.  Rotationally constrained 2,4-diamino-5,6-disubstituted pyrimidines: a new class of histamine H4 receptor antagonists with improved druglikeness and in vivo efficacy in pain and inflammation models. , 2008, Journal of medicinal chemistry.

[14]  J. Bittencourt,et al.  Anatomy, function and regulation of neuropeptide EI (NEI) , 2008, Peptides.

[15]  Shuhui Chen,et al.  Practical Synthesis of Structurally Important Spirodiamine Templates , 2007 .

[16]  V. McKee,et al.  Spirobicyclic Diamines. Part 3: Synthesis and Metal Complexation of Proline-Derived (4,4)- Spirodiamines. , 2007 .

[17]  M. J. Bishop,et al.  6-(4-chlorophenyl)-3-substituted-thieno[3,2-d]pyrimidin-4(3H)-one-based melanin-concentrating hormone receptor 1 antagonist. , 2006, Journal of medicinal chemistry.

[18]  G. Diaz,et al.  Optimization of chromone-2-carboxamide melanin concentrating hormone receptor 1 antagonists: assessment of potency, efficacy, and cardiovascular safety. , 2006, Journal of medicinal chemistry.

[19]  Hui-qiang Zhou,et al.  Melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity. , 2006, Journal of medicinal chemistry.

[20]  Thomas Fey,et al.  Discovery and characterization of aminopiperidinecoumarin melanin concentrating hormone receptor 1 antagonists. , 2005, Journal of medicinal chemistry.

[21]  Michael Czarniecki,et al.  Discovery of melanin-concentrating hormone receptor R1 antagonists using high-throughput synthesis. , 2005, Bioorganic & medicinal chemistry.

[22]  H. Iwaasa,et al.  Chronic intracerebroventricular infusion of MCH causes obesity in mice. Melanin-concentrating hormone. , 2003, American journal of physiology. Endocrinology and metabolism.

[23]  E. Giralt,et al.  Spirolactams as conformationally restricted pseudopeptides: synthesis and conformational analysis. , 2002, The Journal of organic chemistry.

[24]  Beth Borowsky,et al.  Antidepressant, anxiolytic and anorectic effects of a melanin-concentrating hormone-1 receptor antagonist , 2002, Nature Medicine.

[25]  H. Hsiung,et al.  Targeted disruption of the melanin-concentrating hormone receptor-1 results in hyperphagia and resistance to diet-induced obesity. , 2002, Endocrinology.

[26]  Yuji Ishihara,et al.  T-226296: a novel, orally active and selective melanin-concentrating hormone receptor antagonist. , 2002, European journal of pharmacology.

[27]  Yue Feng,et al.  Melanin-concentrating hormone 1 receptor-deficient mice are lean, hyperactive, and hyperphagic and have altered metabolism , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W Li,et al.  Identification and characterization of a melanin-concentrating hormone receptor , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[29]  J. Chambers,et al.  Molecular Cloning and Functional Characterization of MCH2, a Novel Human MCH Receptor* , 2001, The Journal of Biological Chemistry.

[30]  B. Lowell,et al.  Melanin-concentrating hormone overexpression in transgenic mice leads to obesity and insulin resistance. , 2001, The Journal of clinical investigation.

[31]  L. Slieker,et al.  Melanin-concentrating hormone receptor is a target of leptin action in the mouse brain. , 2001, Endocrinology.

[32]  J. Chambers,et al.  Melanin-concentrating hormone is the cognate ligand for the orphan G-protein-coupled receptor SLC-1 , 1999, Nature.

[33]  Yumiko Saito,et al.  Molecular characterization of the melanin-concentrating-hormone receptor , 1999, Nature.

[34]  W. B. Gleason,et al.  Design, synthesis, and dopamine receptor modulating activity of spiro bicyclic peptidomimetics of L-prolyl-L-leucyl-glycinamide. , 1999, Journal of medicinal chemistry.

[35]  B. Lowell,et al.  Mice lacking melanin-concentrating hormone are hypophagic and lean , 1998, Nature.

[36]  J. Germanas,et al.  Novel Bicyclic Lactams as XaaPro Type VI beta Turn Mimics: Design, Synthesis, and Evaluation. , 1996, The Journal of organic chemistry.

[37]  S. Gammeltoft,et al.  A role for melanin-concentrating hormone in the central regulation of feeding behaviour , 1996, Nature.

[38]  J. Vaughan,et al.  The melanin‐concentrating hormone system of the rat brain: An immuno‐ and hybridization histochemical characterization , 1992, The Journal of comparative neurology.

[39]  J H Welsh,et al.  Synthesis, conformational properties, and antibody recognition of peptides containing beta-turn mimetics based on alpha-alkylproline derivatives. , 1991, Journal of medicinal chemistry.

[40]  J R Brown,et al.  Potent and highly selective neurokinin antagonists. , 1990, Journal of medicinal chemistry.

[41]  F. Faigl,et al.  A CONVENIENT METHOD FOR OPTICAL RESOLUTIONS VIA DIASTEREOISOMERIC SALT FORMATION , 1985 .